Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)

Denis Poddubnyy, Kay‐Geert Hermann, Johanna Callhoff, Joachim Listing, Joachim Sieper

Annals of the Rheumatic Diseases · 2014 · 255 citations · 44 references

References

44